Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Cholangiocarcinoma · Irritable Bowel Syndrome With Diarrhea · RDHL

RedHill Biopharma

RedHill Biopharma patent portfolio — 40 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
8045 Arco Corporate Drive, Suite 120, Raleigh, NC 27617, US HQ
2009 Founded
43 Employees
Public company Type
RDHL · NYSE Ticker
Company details
Status
Public
HQ
8045 Arco Corporate Drive, Suite 120, Raleigh, NC 27617, US
Founded
2009
Employees
43
Programs
14
Drugs
10
Patents
40
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

RedHill Biopharma patents

40 pharmaceutical patents indexed for RedHill Biopharma. 0 expire within 24 months.

RedHill Biopharma has 40 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

40 patents

Patent portfolio

  1. US 12370206

    Therapy for inhibition of single-stranded RNA virus replication

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12115150

    Biomarkers of coronavirus pneumonia

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11931463

    All-in-one fixed-dose combination for treating Helicobacter pylori infection

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11918560

    Serine protease inhibitor for treating coronavirus infection

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11878011

    Method for eradicating Helicobacter pylori infection in patients regardless of body mass index

    Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11786541

    Inhibitor of sphingosine kinase 2 for treating Ebola

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11633385

    Combination compositions for treatment of cancer

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11590154

    Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11471448

    Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11364227

    Sphingosine kinase 2 inhibitor for treating coronavirus infection

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11135172

    Rifabutin-based compositions and methods for treating Helicobacter pylori infection

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11090325

    Compositions for treating ebola virus infection

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11090326

    Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11058671

    Formulations and methods of manufacturing formulations for use in colonic evacuation

    Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11052073

    Sphingosine kinase 2 inhibitor for treating coronavirus infection

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11045453

    Serine protease inhibitor for treating coronavirus infection

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10946000

    Method for treating cancer with combination therapy

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10898439

    Methods for treating helicobacter pylori infection

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10765691

    Method for treating crohn's disease using triple antimicrobial all-in-one formulation

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10668050

    Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10543222

    Therapy for inhibition of single-stranded RNA virus replication

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10493065

    Formulations and methods of manufacturing formulations for use in colonic evacuation

    Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10463654

    Combination therapies for treating cancer

    Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10434114

    Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10238606

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10166219

    Formulations and methods of manufacturing formulations for use in colonic evacuation

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10143702

    Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

    Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10105379

    Pharmaceutical compositions comprising three antibiotics

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9974800

    Therapy for inhibition of single-stranded RNA virus replication

    Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9901638

    Composition and method for treating an autoimmune disease

    Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9844540

    Combination therapies for treating cancer

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9675588

    Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9636305

    Antiemetic extended release solid dosage forms

    Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9603806

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9498445

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9314477

    Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9198926

    Methods and compositions comprising rifabutin, clarithromycin, and clofazimine

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9072763

    Methods and compositions for treating inflammatory bowel disease

    Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9050263

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8343511

    Methods and compositions for treating inflammatory bowel disease

    Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does RedHill Biopharma have?

40 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do RedHill Biopharma patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.